wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38638858-7F35B66E-B9B0-4DFD-BEE9-042FBA5D3008
Q38638858-7F35B66E-B9B0-4DFD-BEE9-042FBA5D3008
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38638858-7F35B66E-B9B0-4DFD-BEE9-042FBA5D3008
Should we be combining local tumor therapies with immunotherapies as standard?
P2860
Q38638858-7F35B66E-B9B0-4DFD-BEE9-042FBA5D3008
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38638858-7F35B66E-B9B0-4DFD-BEE9-042FBA5D3008
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
beff6d884ede37a4a2d1e95825b2ffa65d37cb56
P2860
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma